While the gastrointestinal side effects of GLP-1s are very common and manageable for many, between 15% and 25% of people simply can't tolerate them
Adenomatous polyps, Barretts esophagus, actinic keratoses, cervical dysplasia, and similar conditions represent tissue already partway down the path toward malignancy
10.18632/aging.100927 12 DolleryC
Here are some suggested comparison doses for managing type 2 diabetes, according to the ADA: These dosage conversions are just a general guide, and may vary depending on the circumstances
doi: 10.1080/1745039X.2017.1421340 28 TamaiIOhashiRNezuJYabuuchiHOkuAShimaneMet al
It is still being studied in clinical trials, so its long-term safety is not fully known yet